Thozalinone Explained: What It Is & Why It Matters

Published:

Thozalinone is a man-made stimulant drug. It makes your brain release more dopamine, a chemical related to mood and motivation. In the past, it was tested as an antidepressant and an appetite suppressant. It’s not used by doctors anymore.

Here’s what you need to know:

DetailInformation
Other NamesStimsen, CL-39808, Tozalinone
Drug ClassDopaminergic Stimulant, Psychostimulant
Former Medical UseAntidepressant, Appetite Suppressant
Typical Half-LifeAbout 4–6 hours
Structural FamilyOxazolidinone derivative

How Thozalinone Works in the Brain

Dopamine & Norepinephrine: What It Does

Thozalinone tells certain brain cells to release more dopamine. It also slightly increases norepinephrine. If you want to look into the technical research, there’s info from the University of Minnesota program.

This drug works by making your brain release more of these chemicals, not by blocking how they’re cleared away. That’s different from how most antidepressants work.

When dopamine goes up, people often feel better, more awake, and sometimes less hungry. It doesn’t really do much with serotonin.

Thozalinone vs. Classic Stimulants

FeatureThozalinone (old studies)Amphetamine
Main ActionBoosts dopamine releaseCauses release and blocks reuptake
Appetite SuppressionKnown to last longerStrong, shorter-lasting
Heart Side EffectsLower riskCan raise heart rate, blood pressure
Abuse RiskLowerHigher

Old animal and human studies showed it lowered appetite well, didn’t affect the heart as much, and wasn’t as addictive as amphetamines.

Those looking to buy Thozalinone online can find it listed on Express Highs. 

Past Medical Uses: Antidepressant, Weight Loss, and More

Doctors used Thozalinone for a while.

As an Antidepressant

It was sold in Europe as Stimsen.

One of the important studies happened in 1966: A double-blind, placebo-controlled trial by Gallant and others. They tested Thozalinone on people with depression, but the details about how many people and who they were aren’t clear. Some sources say around 120 people took part, but this isn’t confirmed.

Doses were from 50 to 150 mg per day. Improvements in mood were measured using standard depression scales. People on Thozalinone did better than those on placebo. Some smaller European studies reported about 65% of hard-to-treat patients felt better, though details are limited.

Side effects? The most common were trouble sleeping, dry mouth, and feeling jittery.

The main mood boost comes from more dopamine. It seemed to cause fewer side effects than older medicines.

For Weight Loss and Parkinson’s

Animal studies showed it worked well for appetite control, sometimes better than amphetamine. Some thought it might help in Parkinson’s due to the dopamine effect, but it wasn’t adopted.

Doctors stopped using it because there isn’t enough modern evidence or safety data.

Effects: What Was Noticed

Good Effects at Usual Doses

From old research, users felt:

  • Happier and more interested in things
  • More physical and mental energy
  • Less hungry
  • More motivated and focused

Again, this is based on small, older studies.

Common Side Effects and Safety

Typical issues included:

  • Trouble sleeping
  • Feeling jittery or restless
  • Dry mouth

It didn’t seem to cause many heart problems or blood pressure increases. High doses in animals didn’t lead to seizures.

But there’s a limitation: There’s only data for short periods. No studies longer than two months. We don’t know about effects on the heart, liver, kidneys or nerves if used long-term.

Why Thozalinone Isn’t Used Now

Missing Evidence

It hasn’t been tested in:

  • Large groups of people
  • For long-term safety
  • To find rare side effects

Regulators want stronger evidence. Better medications have become available.

Detailed information about how the body handles it isn’t available: Nothing about peak levels, how fast it gets into your system, or how your body clears it out. It’s probably processed by the liver and leaves through the kidneys.

Abuse and Dependence

Reports say people didn’t abuse it as much as amphetamines or pemoline. No reports of addiction or withdrawal in clinics.

No direct studies compare its addictive potential to amphetamines.

For amphetamines, the addictive potential is well-documented. Pemoline, another stimulant, had less abuse but was limited due to liver risks.

Most of what we know is from old records, not the modern tests used for today’s medications.

It’s mostly not controlled. It’s in a gray area. Not approved as a medicine anywhere.

RegionTypical Status
USUnscheduled, only sold as a research chemical
EU / EuropeNot approved; could be covered by new substance rules
CanadaNo specific laws
UKNot scheduled
AustraliaNot scheduled
JapanNo restrictions
ChinaNot listed
BrazilNot scheduled
IndiaNo specific rules
WorldwideUsually unscheduled, research use only

It isn’t a narcotic and doesn’t fall under international cocaine/heroin rules. No research chemical bans at this time.

If it’s sold for human use, that’s a different situation. Laws can change.

Why “Research Chemical” Isn’t Safe

Anything labeled “for research use” is not meant for people. No one checks how pure it is or what’s really inside. There’s a legal risk if you buy it.

If you have depression, want to lose weight, or have Parkinson’s, talk to a doctor. Don’t self-treat.

Comparing Thozalinone to Other Drugs

How It Compares

SubstanceMain ActionApproved UsesAbuse RiskHeart Side Effects
ThozalinoneReleases dopamineHistoric antidepressantLowerLower
AmphetamineReleases and blocks reuptakeADHD, narcolepsyHigherHigher
PemolineLess powerful dopamine effectADHD (not used now)Lower than amphetamineLiver problems, heart risk

It looked safer in some ways. Today’s drugs have more safety data.

Compared to Modern Antidepressants

We don’t know if it works better or worse than things like Prozac or Wellbutrin. New medications are much better studied.

Buying Thozalinone: What to Know

Where People Buy It

Some companies sell it as a powder, labeled “not for human use”. It usually goes for tens of dollars per gram.

Just the facts , not a suggestion to buy.

Sold as a Research Chemical

Some niche sites list it. For example, some mention it might be at sites like ExpressHighs.

But: it’s not an approved medicine. It might be risky or poor quality. Check your local laws. Don’t use it to treat health problems.

Key Takeaways

  • Dopamine-releasing stimulant, once tried as an antidepressant and for weight loss.
  • Older studies say it’s effective with fewer heart risks than some other stimulants.
  • No big or long-term studies have been done.
  • Legal gray zone , available as a research chemical, not scheduled in most places.
  • For health issues, talk to a doctor.

Frequently Asked Questions

1. How fast does Thozalinone work?
Animal data suggests it starts in about an hour, peaks after 1 to 2 hours.

2. Is Thozalinone an amphetamine?
No. It’s a different kind of chemical that releases dopamine.

3. Why isn’t it used as a medicine today?
We don’t have big or long-term studies. Newer medicines have stronger evidence.

4. Is it legal to buy Thozalinone?
In many places, it isn’t scheduled but isn’t approved as a medicine. It’s in a legal gray area. Check your local rules.

5. What do we know about how the body handles Thozalinone?
Not much , no detailed data. It probably goes through the liver and kidneys.

6. Is it safe long-term?
No one knows. No studies have looked at its safety beyond 8 weeks.

Disclaimer

The information provided in this article is intended for informational purposes only and does not constitute medical, legal, pharmaceutical, or professional advice of any kind. Express Highs makes no representations or warranties regarding the accuracy, completeness, or suitability of the content for any particular purpose. Readers should not rely on this content as a substitute for advice from a qualified medical professional, legal counsel, or other relevant expert.
The products and substances discussed on this blog may be subject to varying legal restrictions depending on your country, region, or jurisdiction. It is the sole responsibility of the reader to be aware of and comply with all applicable local, national, and European Union laws and regulations before purchasing, possessing, or using any product referenced herein. Express Highs accepts no liability for any consequences arising from actions taken based on the content of this article.
This blog is intended for adults only. By reading this content, you confirm that you are of legal age in your jurisdiction.
Nothing in this article is intended to diagnose, treat, cure, or prevent any disease or medical condition. Any health-related claims discussed are not evaluated by the European Food Safety Authority (EFSA) or any other regulatory body unless explicitly stated.
Express Highs reserves the right to update or remove content at any time without notice. All content is published in good faith and for general informational purposes only.

Alex Marin
Alex Marinhttps://blog.expresshighs.com
Alex Marin is a harm reduction writer, independent researcher, and longtime observer of emerging psychoactive trends. With over a decade spent navigating the shifting landscape of cannabinoids, research chemicals, and psychedelic culture, Alex specializes in translating complex pharmacology and policy changes into practical, real-world guidance. Drawing on a background in behavioral science and grassroots drug education, Alex’s work focuses on one core principle: informed choices reduce harm. From first-time cannabis users to experienced psychonauts, their writing is designed to meet readers where they are—without judgment, hype, or fearmongering. Alex has contributed to multiple online publications covering CBD science, evolving drug laws, and safer-use strategies. At the Express Highs Blog, they break down topics like dosage, substance interactions, and risk awareness—helping readers navigate a fast-moving market where new compounds and regulations appear almost daily. When not writing, Alex collaborates with harm reduction communities, tracks global policy shifts, and tests the latest data against real-world user experiences. Their goal is simple: clear information, fewer bad trips, and smarter decisions.

Related articles

Recent articles